4.7 Article

Cognition- and circuit-based dysfunction in a mouse model of 22q11.2 microdeletion syndrome: effects of stress

Journal

TRANSLATIONAL PSYCHIATRY
Volume 10, Issue 1, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41398-020-0687-z

Keywords

-

Categories

Funding

  1. Innovative Medicines Initiative Joint Undertaking (IMI) [115008]
  2. INSERM, University Paris Descartes
  3. La Fondation Deniker

Ask authors/readers for more resources

Genetic microdeletion at the 22q11 locus is associated with very high risk for schizophrenia. The 22q11.2 microdeletion (Df(h22q11)/+) mouse model shows cognitive deficits observed in this disorder, some of which can be linked to dysfunction of the prefrontal cortex (PFC). We used behavioral (n = 10 per genotype), electrophysiological (n = 7 per genotype per group), and neuroanatomical (n = 5 per genotype) techniques to investigate schizophrenia-related pathology of Df(h22q11)/+ mice, which showed a significant decrease in the total number of parvalbumin positive interneurons in the medial PFC. The Df(h22q11)/+ mice when tested on PFC-dependent behavioral tasks, including gambling tasks, perform significantly worse than control animals while exhibiting normal behavior on hippocampus-dependent tasks. They also show a significant decrease in hippocampus-medial Prefrontal cortex (H-PFC) synaptic plasticity (long-term potentiation, LTP). Acute platform stress almost abolished H-PFC LTP in both wild-type and Df(h22q11)/+ mice. H-PFC LTP was restored to prestress levels by clozapine (3 mg/kg i.p.) in stressed Df(h22q11)/+ mice, but the restoration of stress-induced LTP, while significant, was similar between wild-type and Df(h22q11)/+ mice. A medial PFC dysfunction may underlie the negative and cognitive symptoms in human 22q11 deletion carriers, and these results are relevant to the current debate on the utility of clozapine in such subjects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development

Steve P. H. Alexander, Jane F. Armstrong, Anthony P. Davenport, Jamie A. Davies, Elena Faccenda, Simon D. Harding, Francesca Levi-Schaffer, Janet J. Maguire, Adam J. Pawson, Christopher Southan, Michael Spedding

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Review Medicine, General & Internal

Neurodevelopment and cannabis

M. -O. Krebs, F. Demars, A. Frajerman, O. Kebir, T. Jay

BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE (2020)

Editorial Material Immunology

Guide to Immunopharmacology: a database to boost immunology education, research and therapy

Simon Milling, Michael Spedding, Pasquale Maffia

IMMUNOLOGY (2020)

Article Pharmacology & Pharmacy

Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseases

Alexandra Bouscary, Cyril Quessada, Frederique Rene, Michael Spedding, Alexandre Henriques, Shyuan Ngo, Jean-Philippe Loeffler

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Article Pharmacology & Pharmacy

Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet

Mikael Hoffmann, Robert Vander Stichele, David W. Bates, Johanna Bjorklund, Steve Alexander, Marine L. Andersson, Ane Auraaen, Marion Bennie, Marja-Liisa Dahl, Birgit Eiermann, Werner Hackl, Tora Hammar, Paul Hjemdahl, Sabine Koch, Ilkka Kunnamo, Herve Le Louet, Papapetrou Panagiotis, Lembit Raego, Michael Spedding, Hanna M. Seidling, Dina Demner-Fushman, Lars L. Gustafsson

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)

Article Pharmacology & Pharmacy

Brain circuits at risk in psychiatric diseases and pharmacological pathways

Michael Spedding, Sumantra Chattarji, Charlotte Spedding, Therese M. Jay

Summary: This review focuses on key brain circuits and their role in health and disease, as well as the impact of upbringing, stress, genetics, and pharmacotherapy on psychiatric diseases.

THERAPIE (2021)

Article Clinical Neurology

Fluoroethylnormemantine, A Novel Derivative of Memantine, Facilitates Extinction Learning Without Sensorimotor Deficits

Briana K. Chen, Gwenaelle Le Pen, Adam Eckmier, Gilles Rubinstenn, Therese M. Jay, Christine A. Denny

Summary: The study showed that compared to memantine, fluoroethylnormemtantine (FENM) did not produce nonspecific side effects in animal experiments, reduced immobility in the forced swim test, and significantly facilitated fear extinction learning.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)

Review Cell Biology

Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases

Alexandra Bouscary, Cyril Quessada, Frederique Rene, Michael Spedding, Bradley J. Turner, Alexandre Henriques, Shyuan T. Ngo, Jean-Philippe Loeffler

Summary: Sphingolipids play crucial roles in the development and maintenance of the nervous system, with dysregulated metabolism being linked to specific neurodegenerative diseases. Current research primarily focuses on ALS, seeking potential treatments that target sphingolipid metabolism in neurodegenerative diseases.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials

Simon D. Harding, Jane F. Armstrong, Elena Faccenda, Christopher Southan, Stephen P. H. Alexander, Anthony P. Davenport, Adam J. Pawson, Michael Spedding, Jamie A. Davies

Summary: The IUPHAR/BPS Guide to PHARMACOLOGY has expanded its content in the past two years, focusing on infection, malaria, and antibiotic resistance. It has included a new family of Coronavirus proteins and collaborated with Medicines for Malaria Venture and AntibioticDB to enhance coverage of malaria pharmacology and antibacterials.

NUCLEIC ACIDS RESEARCH (2022)

Article Cell Biology

Phenotypical Screening on Neuronal Plasticity in Hippocampal-Prefrontal Cortex Connectivity Reveals an Antipsychotic with a Novel Profile

Michael Spedding, Claude Sebban, Therese M. Jay, Cyril Rocher, Brigitte Tesolin-Decros, Paul Chazot, Esther Schenker, Gabor Szenasi, Gyorgy Levay, Katalin Megyeri, Jozsef Barkoczy, Laszlo G. Harsing, Ian Thomson, Mark O. Cunningham, Miles A. Whittington, Lori-An Etherington, Jeremy J. Lambert, Ferenc A. Antoni, Istvan Gacsalyi

Summary: Dysfunction in the H-PFC circuit is a critical factor in schizophrenia, and a new drug called EGIS 11150 has been found to induce theta rhythm, enhance H-PFC coherence, and restore long-term potentiation in this circuit. This suggests that phenotypical screening on H-PFC connectivity can uncover novel antipsychotics.

CELLS (2022)

Review Pharmacology & Pharmacy

Environmental pharmacology-Dosing the environment: IUPHAR review 36

Christopher N. Connolly, Stephen P. H. Alexander, Jamie A. Davies, Michael Spedding

Summary: The article proposes the application of standard pharmacological principles to assess the dosing of the environment and suggests the concept of an "environmental therapeutic window" for risk assessment of pesticides. To achieve this, a freely accessible database containing quantitative data on pesticide action is needed.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Meeting Abstract Biochemistry & Molecular Biology

GM1 oligosaccharide as a novel neuroprotective agent for amyotrophic lateral sclerosis

M. Fazzari, A. Henriques, G. Lunghi, L. Mauri, M. G. Ciampa, G. Tedeschi, N. Mitro, S. Sonnino, M. Spedding, E. Chiricozzi

FEBS OPEN BIO (2022)

No Data Available